BG106513A - New class of bioactive glycoproteins - Google Patents

New class of bioactive glycoproteins

Info

Publication number
BG106513A
BG106513A BG106513A BG10651302A BG106513A BG 106513 A BG106513 A BG 106513A BG 106513 A BG106513 A BG 106513A BG 10651302 A BG10651302 A BG 10651302A BG 106513 A BG106513 A BG 106513A
Authority
BG
Bulgaria
Prior art keywords
glycoproteins
new class
glycoprotein
bioactive
vertebrates
Prior art date
Application number
BG106513A
Other languages
Bulgarian (bg)
Other versions
BG65084B1 (en
Inventor
Виктория ЯМСКОВА
Игорь ЯМСКОВ
Алексей РЬIКОВ
Original Assignee
Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" filed Critical Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А"
Priority to BG106513A priority Critical patent/BG65084B1/en
Publication of BG106513A publication Critical patent/BG106513A/en
Publication of BG65084B1 publication Critical patent/BG65084B1/en
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a bioactive chemical composition, more specifically to proteins and can be used in medicine, veterinary and cell biology. The inventive glycoproteins are extracted from an intercellular space of the tissue of various organs, blood serum and bile of vertebrates (human beings and animals). Said glycoproteins have a high biological activity in super low doses at a concentration ranging from 10-12 to 10-29 mol/liter and lower. It is thus possible to produce a pharmaceutical form including glycoprotein in an effective quantity and a pharmaceutically acceptable carrier. The glycoprotein protein produced finds application as a medicamentous form. 3 claims, 29 figures
BG106513A 2002-03-13 2002-03-13 New class of bioactive glycoproteins Active BG65084B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG106513A BG65084B1 (en) 2002-03-13 2002-03-13 New class of bioactive glycoproteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG106513A BG65084B1 (en) 2002-03-13 2002-03-13 New class of bioactive glycoproteins

Publications (2)

Publication Number Publication Date
BG106513A true BG106513A (en) 2002-12-29
BG65084B1 BG65084B1 (en) 2007-02-28

Family

ID=38057216

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106513A Active BG65084B1 (en) 2002-03-13 2002-03-13 New class of bioactive glycoproteins

Country Status (1)

Country Link
BG (1) BG65084B1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2720704C2 (en) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg New glycoprotein, process for its production and its uses
DE2726886A1 (en) * 1977-06-15 1979-01-18 Behringwerke Ag NEW GLYCOPROTEIN AND METHOD FOR THE PRODUCTION THEREOF
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
NZ199752A (en) * 1981-02-27 1984-11-09 Otsuka Pharma Co Ltd Glycoproteins and immunoactive compositions
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
US4835259A (en) * 1984-09-14 1989-05-30 Scripps Clinic And Research Foundation Merozoite surface glycoproteins
EP0201878A3 (en) * 1985-05-10 1987-04-15 Siemens Aktiengesellschaft Circuit arrangement with a positive potential switching n channel mos transistor
RU2136695C1 (en) * 1998-03-18 1999-09-10 ЗАОПП "Эндо-Фарм-А" Serum glycoprotein showing biological activity at superlow doses

Also Published As

Publication number Publication date
BG65084B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
Mülling et al. How structures in bovine hoof epidermis are influenced by nutritional factors.
Segal et al. Protein turnover and lysosome function
GEP20022804B (en) Erythropoietin Derivatives
EA200600076A1 (en) COMPOSITIONS AND METHODS OF INCREASING THE ACTIVITY OF TELOMERASE
DE69922933D1 (en) APPLICATIONS FOR HUMAN NON AUTOLOGOLOGY, MESENCHYMAL STEM CELLS
BR0109494A (en) Production of recombinant blood clotting factors in human cell lines
NO20053077L (en) Therapeutic formulations for the treatment of beta-amyloid-related diseases.
ATE242633T1 (en) DIALKYLFUMARATE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
EA200401467A1 (en) PEPTIDES OBTAINED FROM KASEIN, AND THEIR APPLICATION IN THERAPY
EA199900861A1 (en) TRACKED PROTEINS, RELATED GROWTH ENDOTHELIUM GROWTH FACTOR
DK1246826T3 (en) Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical preparations comprising these esters
DE50004018D1 (en) USE OF NATURAL PEPTIDES AS ANTIBIOTICALLY ACTIVE SUBSTANCES FOR THE TREATMENT OF BACTERIAL INFECTIONS
ATE277628T1 (en) TREATMENT OF HEMATOPOIETIC CELLS WITH CXCR4 AGONISTS
EP2292255A3 (en) Stable therapeutical proteins
DE69935078D1 (en) A MUTANT PHOSPHOLAMBAN MOLECULES AND THEIR USE FOR THE TREATMENT OF HEART DISEASES AND HEART FAILURES
DE69835680D1 (en) THERAPEUTIC USE OF SMR1 PROTEIN AND ITS ACTIVE DERIVATIVES
DE60331871D1 (en) Pharmaceutical compound and methods of treatment of human carcinoma using arginine withdrawal
MXPA05008704A (en) Fusion proteins of interferon alpha muteins with improved properties.
BR0311371A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
BG106513A (en) New class of bioactive glycoproteins
UA91488C2 (en) New class of physiologically active glycoproteins
CN108794574B (en) Antioxidant active peptide and application thereof
EA200401295A1 (en) STATIN THERAPY TO ENHANCE SUPPORT OF COGNITIVE FUNCTION
ATE239492T1 (en) USE OF A BPI PROTEIN TO PRODUCE A MEDICATION FOR THE TREATMENT OF CHRONIC HEART DISEASE
ATE303401T1 (en) FRAGMENTS OF THE VIRUS PROTEIN 2 OR 3 OF THE POLYOMAVIRUS AS TRAVIES FOR ACTIVE INGREDIENTS